IsoRay Receives FDA Response to 510(k) Application for GammaTile(TM)
Additional Testing for GammaTile Planned for Completion by Year-End 2017
RICHLAND, Wash., July 6, 2017 -- (Healthcare Sales & Marketing Network) -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medi... Devices, Oncology, FDA IsoRay, GammaTile, radiotherapy, brachytherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2017 Category: Pharmaceuticals Source Type: news
New Analysis Reveals First-Line Treatment Data on SIR-Spheres(R) Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic colorectal cancer (mCRC) patients with right-sided primary tum... Devices, Oncology Sirtex Medical, SIR-Spheres, Y-90 resin, microspheres, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2017 Category: Pharmaceuticals Source Type: news
Robot-assisted Implantation of Brachytherapy Catheters Promising in Bladder Cancer Robot-assisted Implantation of Brachytherapy Catheters Promising in Bladder Cancer
Robot-assisted laparoscopic (RAL) implantation of brachytherapy catheters (BTC) is a minimally invasive alternative to open retropubic surgery, researchers from the Netherlands report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 27, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news
IsoRay touts another ‘ 100% ’ study
IsoRay (NYSE:ISR) today released data from a study of its Cesium-131 brachytherapy for treating patients with large brain metastases, touting a 100% freedom from local progression.
Results from the study were published in the International Journal of Radiation Oncology, Biology, Physics, the Richland, Wash.-based company said.
In the study, researchers assessed the impact of low-dose rate Cesium-131 brachytherapy on local control and radionecrosis in 42 patients treated for a total of 46 large brain metastases. Patients in the trial underwent surgical resection with intra-operative palcement of standard Cesium-131 seeds a...
Source: Mass Device - June 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Oncology IsoRay Source Type: news
Elekta points to study of older lung cancer patients
Radiation oncology vendor Elekta is highlighting research that found stereotactic...Read more on AuntMinnie.comRelated Reading:
Elekta debuts MR-linac radiation therapy system at ESTRO
Varian, Elekta settle patent dispute
Elekta nabs Canadian Medical Device License
Elekta gets FDA clearance for brachytherapy applicator
Elekta to support ASTRO safety initiative (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 15, 2017 Category: Radiology Source Type: news
Prostate cancer brachytherapy: Can I pass radiation to others?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - June 3, 2017 Category: Consumer Health News Source Type: news
Eckert & Ziegler to buy German firms
Isotope technology firm Eckert & Ziegler beat out the competition to acquire...Read more on AuntMinnie.comRelated Reading:
Eckert & Ziegler reports loss in Q4
Eckert & Ziegler to produce pancreatic cancer agent
Eckert & Ziegler warns of lower profit in 2013 report
Eckert & Ziegler posts modest sales uptick
Eckert & Ziegler acquires brachytherapy firm (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 24, 2017 Category: Radiology Source Type: news
Brachytherapy: Alternative to Surgery in Penile Cancer? Brachytherapy: Alternative to Surgery in Penile Cancer?
The largest study to date of the use of brachytherapy in penile cancer showed high rates of survival and allowed men to avoid surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Prostate Cancer Patients Satisfed With HDR Brachytherapy Prostate Cancer Patients Satisfed With HDR Brachytherapy
A single outpatient treatment with high-dose-rate (HDR) brachytherapy for prostate cancer was associated with low toxicity and high quality of life.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 9, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news
ESTRO: Survival in Pancreatic Ca Rises with RT Dose
(MedPage Today) -- Also: cartoons during RT, brachytherapy for penile cancer (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 9, 2017 Category: Gastroenterology Source Type: news
Elekta debuts MR-linac radiation therapy system at ESTRO
Radiation oncology vendor Elekta is using this week's annual meeting of the...Read more on AuntMinnie.comRelated Reading:
Varian, Elekta settle patent dispute
Elekta nabs Canadian Medical Device License
Elekta gets FDA clearance for brachytherapy applicator
Elekta to support ASTRO safety initiative
Varian claims favorable ruling in Elekta patent suit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2017 Category: Radiology Source Type: news
Brachytherapy rather than surgery is a good option for cancer of the penis
(European Society for Radiotherapy and Oncology (ESTRO)) Results from the largest group of men treated for cancer of the penis by a single institution have shown that treatment with brachytherapy is a good option that can be used instead of surgery in many cases. The study, presented at the 36th annual congress of the European SocieTy for Radiotherapy& Oncology, is important because penile cancer is extremely rare and so it is difficult to gather enough evidence to show that one type of treatment is better than another. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2017 Category: Global & Universal Source Type: news
Medical News Today: Advanced liver cancer: Selective internal radiation therapy safer than sorafenib
A phase III trial of selective internal radiation therapy for hepatocellular carcinoma has found the treatment is safer and just as effective as sorafenib. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 25, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Varian, Elekta settle patent dispute
Radiation oncology firm Varian Medical Systems announced it has reached a confidential...Read more on AuntMinnie.comRelated Reading:
Elekta nabs Canadian Medical Device License
Brazil hospital uses Varian's Calypso system
Varian wins Chinese contract
Elekta gets FDA clearance for brachytherapy applicator
Varian completes Imaging Components spin-off
Elekta to support ASTRO safety initiative (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 4, 2017 Category: Radiology Source Type: news
Updated Guideline on Brachytherapy in Prostate Cancer Updated Guideline on Brachytherapy in Prostate Cancer
The American Society of Clinical Oncology and Cancer Care Ontario have issued updated guidelines on brachytherapy for prostate cancer patients. (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 30, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news
